In fact, tumor size was significantly reduced in 3 out of 8 mice treated with anti-CTLA-4 alone, with complete tumor eradication in two of them, whereas tumor size was reduced in all the mice receiving the combined treatment, with complete eradication in 7 out of 8 of them. This evidence concerns the gene CTLA4 and neoplasm.